0001231919-25-000205.txt : 20250917 0001231919-25-000205.hdr.sgml : 20250917 20250916175401 ACCESSION NUMBER: 0001231919-25-000205 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250917 DATE AS OF CHANGE: 20250916 EFFECTIVENESS DATE: 20250917 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Merge Bio Therapeutics Corp CENTRAL INDEX KEY: 0002086124 ORGANIZATION NAME: EIN: 333100833 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-557706 FILM NUMBER: 251318277 BUSINESS ADDRESS: STREET 1: 1 KENDALL SQUARE, BUILDING 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-286-2631 MAIL ADDRESS: STREET 1: 1 KENDALL SQUARE, BUILDING 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0002086124 Merge Bio Therapeutics Corp 1 KENDALL SQUARE, BUILDING 200 CAMBRIDGE MA MASSACHUSETTS 02139 617-286-2631 DELAWARE None None Corporation true 2025 Wesley Wong c/o Merge Bio Therapeutics Corporation 1 Kendall Square, Building 200 Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Promoter Steve Liapis c/o Merge Bio Therapeutics Corporation 1 Kendall Square, Building 200 Cambridge MA MASSACHUSETTS 02139 Director Elias Quijano c/o Merge Bio Therapeutics Corporation 1 Kendall Square, Building 200 Cambridge MA MASSACHUSETTS 02139 Director Clinton Hansen c/o Merge Bio Therapeutics Corporation 1 Kendall Square, Building 200 Cambridge MA MASSACHUSETTS 02139 Executive Officer Promoter Mark Lipstein c/o Merge Bio Therapeutics Corporation 1 Kendall Square, Building 200 Cambridge MA MASSACHUSETTS 02139 Promoter Darren Yang c/o Merge Bio Therapeutics Corporation 1 Kendall Square, Building 200 Cambridge MA MASSACHUSETTS 02139 Promoter Other Decline to Disclose 06b false 2025-08-26 false true false 0 14999979 4999998 9999981 false 1 0 0 0 false Merge Bio Therapeutics Corp /s/ Wesley Wong Wesley Wong Chief Executive Officer 2025-09-16